Immunotherapy in urological cancers: new paradigms and a systematic review of clinical trials and real-world evidence
Nabil Ismaili, Sanaa El Majjaoui · 2026
Read Immunotherapy in urological cancers: new paradigms and a systematic review of clinical trials and real-world evidence by Nabil Ismaili, Sanaa El Majjaoui (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13506281.txt.
Description
A peer-reviewed research article from Europe PMC (2026). IntroductionThe therapeutic landscape of urological cancers has undergone a paradigm shift with the advent of immunotherapy. This systematic review synthesizes clinical trials that have established new standards of care, complemented by evidence on immunotherapy-radiotherapy combinations and real-world data.MethodsA comprehensive search of PubMed/MEDLINE and Embase (2010–2026) identified phase II/III trials evaluating ICIs, ADCs, vaccines, or cellular therapies, as well as immunoradiotehrapy, observational studies, and registries reporting real-world outcomes.ResultsFifty-three clinical trials met the inclusion criteria: bladder cancer (n=14), kidney cancer (n=21), and prostate cancer
Catalog record
| CREATOR | Nabil Ismaili, Sanaa El Majjaoui |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 157 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |